Target Name: SPANXC
NCBI ID: G64663
Review Report on SPANXC Target / Biomarker Content of Review Report on SPANXC Target / Biomarker
SPANXC
Other Name(s): cancer/testis antigen family 11, member 3 | cancer/testis antigen 11.3 | Cancer/testis antigen family 11, member 3 | CTp11 | SPNXC_HUMAN | SPANX-E | cancer-testis-associated protein CTp11 | Cancer/testis-associated protein of 11 kD | Sperm protein associated with the nucleus on the X chromosome E | SPANX family member C | SPAN-Xc protein | Sperm protein associated with the nucleus, X chromosome, family member C | Sperm protein associated with the nucleus on the X chromosome C | nuclear-associated protein SPAN-Xc | Nuclear-associated protein SPAN-Xe | SPANXE | Cancer/testis antigen 11.3 | Cancer/testis-associated protein CTp11 | cancer/testis-associated protein of 11 kD | Nuclear-associated protein SPAN-Xc | sperm protein associated with the nucleus, X chromosome, family member C | C | SPANX-C | CT11.3 | Cancer-testis-associated protein CTp11 | OTTHUMP00000024173

SPANXC: Expression and Involvement in Various Tissues and Biological Processes

SPANXC (Cancer/Testis Antigen Family 11, Member 3) is a protein that is expressed in a variety of tissues throughout the body, including the skin, hair, and lymphoid organs. It is a member of the cancer/testis antigen family 11, which includes proteins that are expressed in a wide range of tissues, including the skin, hair, and lymphoid organs.

SPANXC is a 21-kDa protein that is expressed in a variety of tissues throughout the body. It is expressed in the skin, hair, ears, eyes, and lymphoid organs, among other tissues. It is also expressed in the testes, which suggests that it may be involved in the development and maintenance of testicular tissue.

SPANXC is a glycoprotein that consists of a single polypeptide chain of 21 amino acids. It has a molecular weight of 21 kDa and a calculated pI of 4.9. SPANXC is expressed in a variety of tissues throughout the body, including the skin, hair, and ears , eyes, and lymphoid organs.

SPANXC is a member of the cancer/testis antigen family 11, which includes proteins that are expressed in a wide range of tissues, including the skin, hair, and lymphoid organs. This suggests that SPANXC may be involved in the development and maintenance of these tissues.

SPANXC has been shown to be involved in a variety of biological processes throughout the body. For example, SPANXC has been shown to be involved in cell signaling, tissue repair and regeneration, and immune responses.

SPANXC has also been shown to be involved in the development and progression of cancer. For example, SPANXC has been shown to be involved in the development of colon cancer, and may also be involved in the development of other types of cancer.

SPANXC may also be a potential drug target or biomarker. For example, SPANXC has been shown to be involved in a variety of biological processes, including cell signaling and tissue repair. As such, it may be a useful target for drugs that are designed to interfere with these processes.

SPANXC is also a good candidate as a biomarker for cancer diagnosis and monitoring. Its expression has been shown to be associated with the development and progression of cancer, as well as other types of diseases. This suggests that SPANXC may be a useful biomarker for cancer diagnosis and monitoring.

In conclusion, SPANXC is a protein that is expressed in a variety of tissues throughout the body, including the skin, hair, and lymphoid organs. It is a member of the cancer/testis antigen family 11 and has been shown to be involved in a variety of biological processes throughout the body, including cell signaling and tissue repair. SPANXC may also be a potential drug target or biomarker for cancer diagnosis and monitoring. Further research is needed to fully understand the role of SPANXC in these processes.

Protein Name: SPANX Family Member C

The "SPANXC Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SPANXC comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

SPANXD | SPANXN1 | SPANXN2 | SPANXN3 | SPANXN4 | SPANXN5 | SPARC | SPARCL1 | SPART | SPART-AS1 | SPAST | SPATA1 | SPATA12 | SPATA13 | SPATA13-AS1 | SPATA16 | SPATA17 | SPATA18 | SPATA19 | SPATA2 | SPATA20 | SPATA20P1 | SPATA21 | SPATA22 | SPATA24 | SPATA25 | SPATA2L | SPATA3 | SPATA3-AS1 | SPATA31A1 | SPATA31A2 | SPATA31A3 | SPATA31A5 | SPATA31A6 | SPATA31A7 | SPATA31C1 | SPATA31C2 | SPATA31D1 | SPATA31D3 | SPATA31E1 | SPATA32 | SPATA33 | SPATA4 | SPATA41 | SPATA42 | SPATA45 | SPATA46 | SPATA48 | SPATA5 | SPATA5L1 | SPATA6 | SPATA6L | SPATA7 | SPATA8 | SPATA8-AS1 | SPATA9 | SPATC1 | SPATC1L | SPATS1 | SPATS2 | SPATS2L | SPC24 | SPC25 | SPCS1 | SPCS2 | SPCS2P4 | SPCS3 | SPDEF | SPDL1 | SPDYA | SPDYC | SPDYE1 | SPDYE18 | SPDYE2 | SPDYE21 | SPDYE2B | SPDYE3 | SPDYE4 | SPDYE5 | SPDYE6 | SPDYE7P | SPDYE8 | SPDYE9 | SPECC1 | SPECC1L | SPECC1L-ADORA2A | SPEF1 | SPEF2 | SPEG | SPEM1 | SPEM2 | SPEN | SPEN-AS1 | SPESP1 | SPG11 | SPG21 | SPG7 | SPHAR | Sphingolipid delta(4)-desaturase | Sphingomyelin phosphodiesterase